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 We previously demonstrated that co-encapsulation of the potent antioxidant astaxanthin 
(Asx) and tocotrienols into liposomes results in synergistically higher antioxidative activity than the 
calculated additive activity of each individual antioxidant-containing liposome, due to intermolecular 
interactions between terminal ring moieties of the two antioxidants and the polyene chain and the 
triene moiety. We reported that intermolecular interactions depend on the stereochemistry of Asx, 
and change the electronic state of the Asx polyene moiety. Based on these findings, we hypothesized 
that antioxidants that interact with Asx at the terminal ring and polyene moieties may enhance the 
antioxidative activity. Herein, we selected two candidate antioxidants, capsaicin (Cap) and 
resveratrol, based on their structures, in which the compounds exhibit similar characteristics to 
tocotrienols. We evaluated the antioxidative capacities of liposomes co-encapsulating Asx and the 
selected candidates. Based on hydroxyl radical scavenging activity, Cap was found to synergistically 
enhance the antioxidative activity of Asx at an optimal Asx/Cap ratio. Intermolecular interactions 
between Asx and Cap are necessary for the synergistic effect, and the Asx stereoisomer 3R,3’R-form 
(Asx-R) was predicted to most potently interact. Liposomes co-encapsulating Asx-R and Cap 
exhibited clear synergistic antioxidative activity at an optimal ratio, whereas liposomes 
co-encapsulating the other Asx stereoisomer and Cap did not demonstrate such activity. 
Computational chemistry analysis showed that changes in the electronic state of the polyene moiety 
of Asx-R are crucial for the synergistic activity. These results suggest that antioxidants that can 
change the electronic state of Asx via intermolecular interactions may enhance the function of Asx.  
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 As oxidative stress induced by excess reactive oxygen species (ROS) is involved in the 
progression of various diseases, such as arteriosclerosis, dry eye, and ischemic stroke [1-3], 
suppression of oxidative stress by certain therapeutic agents is a feasible therapeutic strategy for the 
treatment of such diseases. In fact, the radical scavenger edaravone has been approved in a limited 
number of countries for the treatment of acute ischemic stroke via suppression of ROS-mediated 
brain damage after cerebral ischemia/reperfusion [4]. Hence, it is expected that antioxidants that 
possess potent ROS-scavenging capabilities could represent potential agents for the prevention and 
treatment of ROS-related diseases.  
 The carotenoid astaxanthin (Asx, 3,3’-dihydroxy-β,β-carotene-4,4’-dione) has been reported 
to be a more potent antioxidant than the representative compounds carotenoid β-carotene and vitamin 
E α-tocopherol for the prevention of singlet oxygen and suppression of lipid peroxidation in 
biological membranes [5-7]. Also, upon incorporation of highly hydrophobic Asx into liposome 
membranes to evaluate antioxidative activity in aqueous conditions, we previously found that Asx 
can effectively scavenge hydroxyl radicals [8]. Moreover, our previous study demonstrated that 
transdermal delivery of liposomes encapsulating Asx (Asx-lipo) via iontophoresis can prevent 
ultraviolet-induced melanin production in the skin due to the potent radical-scavenging ability of Asx 
[9]. Based on these findings, application of Asx may prevent pathological progression of 
ROS-related diseases. In addition, as Asx is broadly used as a cosmetic ingredient and a nutritional 
supplement, its application in humans has been demonstrated to be safe. 
 To increase the antioxidative ability of Asx-lipo, we demonstrated that co-encapsulation of 
Asx and one type of vitamin E, namely α-tocotrienol (α-T3), into liposomes results in synergistically 
higher antioxidative activity in vitro than the calculated additive activity of each of the individual 
antioxidant-containing liposomes [10]. The synergistic effect was shown to result from 
intermolecular interactions via hydrogen bonding between the terminal ring of Asx and the chroman 
ring of α-T3 and via partial interaction of the polyene chain of Asx and the triene chain of α-T3 [10]. 
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We recently reported additional details of the synergistic mechanism, noting that the stereochemistry 
of Asx is an important factor for the higher antioxidative activity of liposomes co-encapsulating Asx 
and α-T3 compared with the additive activity of liposomes encapsulating the individual single agents 
[11]. Moreover, changes in the electronic structures of the polyene moiety upon interaction of Asx 
with α-T3 were suggested to be crucial for the enhancement of their antioxidative activity based on 
results of a computational chemistry analysis. Based on these findings, we hypothesized that other 
antioxidants that can interact with Asx at the terminal ring moiety and the polyene moiety in 
liposomal membranes may enhance the antioxidative activity of Asx. Moreover, liposomes 
co-encapsulating Asx and the candidate compounds may offer new and promising antioxidant 
formulations. 
 In the present study, we selected two candidate antioxidants, capsaicin (Cap) and resveratrol 
(Res), based on their structures, in which the compounds exhibit both phenolic OH and hydrophobic 
side chain group similar to α-T3 (Fig. 1). Cap is an alkaloid found in chili pepper and has an 
analgesic effect as well as antioxidative effects [12,13]. Res is a polyphenol that is known to exhibit 
antioxidative and anti-inflammatory effects, and is found in foods such as red wine and grape peels 
[14,15]. By preparing liposomes encapsulating each candidate antioxidant, we first evaluated their 
antioxidative capacities based on their ability to scavenge hydroxyl radicals. We then evaluated the 
antioxidative effects of liposomes co-encapsulating Asx and the candidate antioxidants in vitro. 
Computational chemistry analysis was carried out to evaluate intermolecular interactions induced in 
liposomes co-encapsulating multiple antioxidants. 
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Materials and methods 
 
Materials 
 Synthetic Asx was purchased from Sigma-Aldrich (St. Louis, USA). 3S,3’S- (Asx-S) was 
gifted from Fuji Chemical Industries (Toyama, Japan). Capsaicin (Cap) was obtained from Wako 
Pure Chemical (Osaka, Japan), and resveratrol (Res) from Tokyo Chemical Industry (Tokyo, Japan). 
Egg phosphatidylcholine (EPC) was purchased from NOF Corporation (Tokyo, Japan). Aminophenyl 
fluorescein (APF) was obtained from Goryo Chemical (Sapporo, Japan). All other reagents used in 
this study were of the highest grade available commercially. 
 
Preparation of liposomes encapsulating Asx and other antioxidants 
 Liposomes composed of EPC, Asx, and other antioxidants were prepared by the thin-film 
method. Chloroform solution containing 2 µmol of EPC, and each of the tested concentrations of Asx 
and the other antioxidants, was added to test tubes and dried using nitrogen gas. The dried lipid film 
was hydrated with 0.2 mL of 10 mM Tris-HCl buffer (pH 7.4) at room temperature, and liposomes 
were prepared by sonication using a bath-type sonicator. The particle sizes of the resultant liposomes 
were measured with a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK). The diameters 
of the liposomes used in this study were determined to be 150‒250 nm. 
 
Evaluation of hydroxyl radical scavenging activity of liposomes 
 The production of hydroxyl radicals was evaluated by measuring the fluorescence intensity 
of APF [16]. To generate hydroxyl radicals, 30 µL of 10 mM H2O2 (final conc.: 1 mM), 45 µL of 
each liposomal suspension at a concentration of 10 mM (final lipid conc.: 1.5 mM), 30 µL of 100 
µM APF solution (final conc.: 10 µM), and 30 µL of 1 mM FeSO4 solution (final conc.: 100 µM) 
were mixed in a test tube. Using this protocol, hydroxyl radicals are generated via the Fenton 
reaction as follows: Fe2+ + H2O2→Fe3+ + OH- +‧OH [17]. After mixing, the fluorescence intensity 
6 
 
(excitation: 490 nm; emission: 515 nm) was measured within 10 seconds with a Tecan Infinite M200 
microplate reader (Salzburg, Switzerland). The decrease rate of the fluorescence intensity of APF in 
each group was calculated as the hydroxyl radical scavenging activity by setting the control group as 
100%. In the control group, 45 µl of 10 mM plane EPC liposomes (final lipid conc.: 1.5 mM) was 
added to the sample tube instead of each antioxidant-containing liposomes. In case of evaluating 
additive antioxidative activity, the final lipid concentration in a test tube was 3.0 mM by adding 45 
µL of two species of antioxidant-containing liposomes, respectively. For evaluating synergistic 
activity, the final lipid concentration in a test tube was also 3.0 mM by adding 45 µL of antioxidants 
co-encapsulating and 45 µL of plain EPC liposomes.  
 
Estimation of the intermolecular interaction energy between each Asx stereoisomer and Cap 
 All calculations were performed using the Gaussian 09 program. The B3LYP-D3(BJ) hybrid 
density functional theory (DFT) was employed, which contains Grimme’s empirical dispersion 
correction (D3(BJ)) term [18]. The minimum energy conformations of the Asx stereoisomers, Asx-S, 
Asx-R, and 3R,3’S-form (Asx-meso), with Cap were first calculated with calculated mechanics. 
Based on the calculated conformations, optimized structures were then predicted using 
semi-empirical molecular calculations. Intermolecular interaction energies were estimated using the 
difference in heats of formation for each of the following combinations: Asx-S-Cap, Asx-R-Cap, and 
Asx-meso-Cap. 
 
Visible absorption spectra of antioxidant-containing liposomes 
 The visible absorption spectra between 400 and 600 nm of liposomes encapsulating Asx-R 
(Asx-R-lipo), liposomes encapsulating Cap (Cap-lipo), and liposomes co-encapsulating Asx-R and 
Cap (Asx-R/Cap-lipo) at a 2:1 molar ratio of Asx-R/Cap were measured with a NanoPhotometer C40 
(Implen GmbH, Munich, Germany). The concentrations of each liposome were the same as 
described above. The absorption spectrum of plain EPC liposomes was subtracted from that of 
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liposomes encapsulating each antioxidant to cancel out the turbidity of the liposomes. 
 
Prediction of the influence of intermolecular interactions with Cap on the electronic state of 
Asx-R 
 Electronic calculations were carried out using the Gaussian 09 program. The initial structure 
of the Asx-R/Cap complex was prepared based on according to previously reported methods [10,19]. 
The geometries of the complex and Asx-R alone were then completely optimized by the 6-31G(d) 
basis set. The zero-point energy (ZPE) corrected hemolytic C-H bond dissociation energy (BDE) was 
calculated at the B3LYP-D3(BJ)/6-311+G(d,p)//B3LYP-D3(BJ)/6-31G(d) level for Asx-R, both in 
the Asx-R/Cap complex and alone. To investigate changes in charge distribution within Asx-R owing 
to complex formation with Cap, Δqi(Asx-R)(=qi(Asx-R)complex-qi(Asx-R)alone), natural population 
analysis [20] was performed at the same level. qi(Asx-R)complex and qi(Asx-R)alone denote the natural 
charges on the i-th atom within Asx-R in the complex and alone, respectively. The contribution of 
hydrogen atoms to Δqi(Asx-R) was summed into the heavy atoms. 
 
Statistical analysis 
 Statistical differences between groups were evaluated using the Student’s t-test. Data are 





Evaluation of antioxidative activity of liposomes encapsulating Cap or Res 
 Because Cap and Res contain both phenolic OH and hydrophobic side chain groups (Fig. 1), 
both of which were shown to be important for intermolecular interaction of α-T3 with Asx in our 
previous studies [10,11], we selected Cap and Res as candidate antioxidants to enhance the 
antioxidative activity of Asx by co-encapsulation into liposomes. First, we evaluated the 
antioxidative activities of liposomes encapsulating Cap (Cap-lipo) and Res (Res-lipo) based on their 
abilities to scavenge hydroxyl radicals. The particle diameters of the liposomes used in the following 
experiments were adjusted to 150-250 nm. We used the reagent APF, which fluoresces upon reaction 
with hydroxyl radicals. Results demonstrated that both Cap-lipo and Res-lipo showed 
dose-dependent hydroxyl radical-scavenging abilities (Fig. 2). Moreover, upon comparison of the 
effect of Cap-lipo and Res-lipo at identical concentrations, the hydroxyl radical-scavenging effect of 
Cap-lipo was found to be higher than that of Res-lipo. 
 
Antioxidative effect of liposomes co-encapsulating Asx and each candidate antioxidant 
Next, we evaluated the hydroxyl radical scavenging activities of liposomes co-encapsulating 
Asx and Cap (Asx/Cap-lipo) or Res (Asx/Res-lipo). The activities were augmented with increasing 
amounts of Asx (Figs. 3A and B). By fixing the concentrations of Cap and Res at 0.94 and 1.88 µM, 
respectively, we sought to identify the optimal ratios of Asx/Cap and Asx/Res that results in the 
highest antioxidative activities compared with the additive effects of each of the individual 
antioxidant-containing liposomes. As shown in Fig. 3A, the activity of Asx/Res-lipo was nearly the 
same as or lower than the calculated additive activities of Asx-lipo and Res-lipo, implying that this 
combination did not exhibit synergistic antioxidative activity. On the other hand, the hydroxyl radical 
scavenging activity of Asx/Cap-lipo was higher than the sum of the activities of Asx-lipo and 
Cap-lipo at an Asx/Cap ratio of 2:1, whereas the activities of Asx/Cap-lipo at other ratios were 
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comparable to the sum of the liposomes containing each of the individual agents (Fig. 3B). By 
mixing Asx-lipo and Cap-lipo at an Asx/Cap ratio of 2:1, or adding Asx/Cap-lipo (Asx:Cap=2:1) in 
test tubes, we evaluated additive and synergistic hydroxyl radical scavenging activities. As shown in 
Fig. 3C, Asx/Cap-lipo (Asx:Cap=2:1) showed a 1.66-fold synergistically higher hydroxyl radical 
scavenging activity compared with the additive activity of liposomes containing individual agents. 
These results suggest that an Asx/Cap ratio of 2:1 is optimal to exert efficient antioxidative activities 
in liposomal membranes. 
 
Comparison of intermolecular interaction energies between stereoisomers of Asx and Cap 
 As a synergistic antioxidative activity was observed upon co-encapsulation of Asx and Cap 
into liposomes at a ratio of 2:1, we hypothesized that intermolecular interactions may be formed 
between Asx and Cap within the liposomal membranes, similar to those observed for liposomes 
co-encapsulating Asx/α-T3 in our previous study [11]. Further, Asx exhibits three known 
stereoisomers, namely 3S,3’S-form (Asx-S), 3R,3’R-form (Asx-R), and 3R,3’S-meso form 
(Asx-meso) [21] (Fig. 1). The synthetic Asx used in our above-mentioned experiments consisted of a 
mixture of these three stereoisomers at a ratio of Asx-S/Asx-R/Asx-meso=1:1:2 [21]. We compared 
the intermolecular interaction energies between the stereoisomers of Asx and Cap by computational 
chemistry analysis. By employing the B3LYP method, the heats of intermolecular interaction of 
Asx-S, Asx-R, and Asx-meso with Cap were determined to be 26.05, 29.04, and 27.62 kcal/mol, 
respectively (Fig. 4). These results suggest that Asx-R forms more energetically stable intermolecular 
interactions with Cap compared to Asx-S and Asx-meso. 
 
Antioxidative activity of liposomes co-encapsulating different stereoisomers of Asx and Cap 
 Based on the differences in the heats of intermolecular interaction between Asx 
stereoisomers, we compared the hydroxyl radical scavenging activities of liposomes 
co-encapsulating Asx-S/Cap (Asx-S/Cap-lipo) and Asx-R/Cap (Asx-R/Cap-lipo). The activity of 
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Asx-S/Cap-lipo was lower than the calculated additive activity of Asx-S-lipo and Cap-lipo (Fig. 5A). 
On the other hand, the activity of Asx-R/Cap-lipo, of which particle size was adjusted to 150-170 nm 
by extrusion through polycarbonate membrane filter with 200-nm pores, was higher than the additive 
activities of Asx-R-lipo and Cap-lipo at Asx/Cap ratios of 1:2 or 1:1, whereas the activities of 
Asx-R/Cap-lipo at other ratios were nearly the same as the sum of those of liposomes encapsulating 
the individual agents (Fig. 5B). By mixing Asx-R-lipo and Cap-lipo at an Asx-R/Cap ratio of 1:2, or 
adding Asx-R/Cap-lipo (Asx-R:Cap=1:2) in test tubes, the additive and synergistic hydroxyl radical 
scavenging activities were evaluated. As shown in Fig. 5C, Asx-R/Cap-lipo (Asx-R:Cap=1:2) 
showed significantly higher (1.48-fold) synergistic hydroxyl radical scavenging activity compared 
with the additive activity of liposomes containing individual agents. These results suggest that the 
stronger intermolecular interactions between Asx-R and Cap compared with Asx-S and Cap 
contributed to the synergistically higher hydroxyl radical scavenging activity at the optimal ratio 
(Asx-R/Cap=1:2). 
  
Changes in electronic state of Asx-R via intermolecular interaction with Cap 
 Our previous study reported that the hydrogen atoms at C3/C3’ in the Asx terminal ring 
moieties act as active sites for scavenging ROS via extraction of a free radical [6] (Fig. 6). The active 
site of Cap for scavenging ROS was also previously reported to be the hydrogen atom at C7, as 
shown by the dotted circle in Fig. 6 [12]. We hypothesized that the reactivity of the active sites of 
Asx-R and Cap may be changed via formation of intermolecular interactions. We estimated the 
activity of Asx-R and Cap by calculating the bond dissociation energy (BDE) between C3 and H for 
Asx, and between C7 and H for Cap. Results showed that the H-C3 BDE in Asx-R alone and 
Asx-R-Cap were 68.82 kcal/mol and 68.56 kcal/mol, respectively. On the other hand, the H-C7 BDE 
in Cap alone and in the Asx-R-Cap complex were 78.36 kcal/mol and 78.33 kcal/mol, respectively 
(Fig. 6). These results imply that, unexpectedly, the reactivity of the active sites of Asx and Cap was 
nearly unchanged via intermolecular interactions.  
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 Asx is known to be able to scavenge free radicals via both the polyene chain as well as the 
terminal ring moieties [6]. Our previous study demonstrated that intermolecular interaction of Asx 
with α-T3 causes changes in the electronic state of the Asx polyene moiety by the presence of the 
double bond in the α-T3 triene moiety [11]. Based on these findings, we hypothesized that a change 
in the electronic state of the Asx-R polyene moiety is induced via intermolecular interaction with Cap 
within the liposomal membranes. To confirm the change in the electronic state of Asx-R, the visible 
absorption spectrum of Asx-R/Cap-lipo prepared at the optimal ratio of 1:2 was compared with the 
combined visible absorption spectra of Asx-R-lipo and Cap-lipo. The spectrum of Asx-R/Cap-lipo, 
which is dominated by Asx-R, was different from the combined spectrum of Asx-R-lipo and Cap-lipo, 
with the peak of the visible absorption being slightly shifted upon co-encapsulation (Fig. 7). These 
results suggest that the electronic state of Asx-R was influenced by intermolecular interactions with 
Cap. 
 Next, the effect of intermolecular interaction with Cap on the electronic structure of Asx-R 
was investigated by computational chemistry. The electronic structures of Asx-R half fragment A, 
which interacted with Cap, were compared with that of free Asx-R fragment B (Fig. 8A). 
Intermolecular interactions with Cap resulted in marked changes in the electronic charges on the C7, 
C8, C9, C12, and C14 atoms in Asx-R (Fig. 8B), while the electronic structures of Cap was nearly 
unchanged (Fig. 8C). Surprisingly, the electronic charges on the C3 and H atoms in Asx-R half 
fragment, which are active sites for scavenging ROS, were unchanged, in contrast to those in Asx-R 
half fragment B. These results suggest that changes in the electronic structures of the polyene moiety 
of Asx-R upon intermolecular interaction may be responsible for the increased synergistic 




 Asx has been reported to be a superior antioxidant compared with representative 
antioxidants such as β-carotene and α-tocopherol, owing to its high activity for prevention of ROS 
production and lipid peroxidation in biological membranes [5-7]. Hence, Asx is not only used as a 
nutritional supplement and a cosmetic ingredient, but may also exhibit the potential as a treatment of 
ROS-related diseases [22-25]. To augment the antioxidative activity of Asx, we previously 
constructed liposomes co-encapsulating Asx and α-T3, and succeeded in the synergistic enhancement 
of the antioxidative activity resulting from intermolecular interactions via hydrogen bonding 
formation between the terminal ring of Asx and the chroman ring of α-T3 in the liposomal 
membranes [10]. We also demonstrated that changes in the electronic structure of the polyene moiety 
of Asx upon interaction with the α-T3 triene moiety were crucial for the synergistic increase in Asx 
antioxidative activity [11]. As the intermolecular interactions in the terminal ring moiety and polyene 
moiety of Asx were demonstrated to be important for the enhancement of the antioxidative activity 
of Asx, we hypothesized that other antioxidants that can also form intermolecular interactions with 
Asx at the terminal ring moiety and the polyene moiety may function as enhancers of the 
antioxidative activity of Asx. 
 As candidate antioxidants for exploring enhancers of Asx activity, we selected Cap and Res 
based on their structures, as they exhibit both phenolic OH and hydrophobic side chain groups, 
similar to α-T3 (Fig. 1). These hydrophobic antioxidants were incorporated into liposomal 
membranes to evaluate their antioxidative activities under aqueous conditions. Also, the particle 
diameters of the liposomes used in the present study were adjusted to 150-250 nm. Thus, the 
antioxidative activities of each liposomal antioxidant could not be influenced by the size of the 
liposomes. Both Cap-lipo and Res-lipo showed dose-dependent hydroxyl radical scavenging effects, 
although the effect of Cap-lipo was higher than that of Res-lipo at the same concentration (Fig. 2). 
Co-encapsulation of Res with Asx resulted in a hydroxyl radical scavenging activity for Asx/Res-lipo 
that was nearly the same or lower than the calculated additive activity of Asx-lipo and Res-lipo (Fig. 
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3A). As to the reason why the combination of Res with Asx did not show enhancement of Asx 
antioxidative activity, we speculate that the benzene ring in the hydrophobic side chain group of Res 
impeded formation of intermolecular interaction with Asx within the liposomal membranes. On the 
other hand, the antioxidative activity of Asx/Cap-lipo (ratio of 2:1) was significantly higher than the 
additive value of liposomes encapsulating the individual agents (Figs. 3B and C). These results 
suggest that Cap may enhance the antioxidative activity of Asx, and that the optimal Asx/Cap ratio in 
the liposomal membranes could be 2:1. 
 To elucidate the underlying mechanism of the synergistic antioxidative activity of 
Asx/Cap-lipo at a ratio of 2:1, intermolecular interactions between Asx and Cap were investigated by 
computational chemistry. The intermolecular interaction energies between Cap and each of the three 
stereoisomers of Asx (Asx-S, Asx-R, and Asx-meso) were calculated. Interestingly, the heats of 
intermolecular interaction were different among the three stereoisomers, with that of the Asx-R-Cap 
complex being the highest (Fig. 4), implying that Asx-R exhibits the most potent intermolecular 
interaction with Cap and that a molecular complex of Asx-R with Cap in liposomal membranes is 
favorable over molecular pairs containing either Asx-S or Asx-meso. Hydroxyl radical scavenging 
activities of liposomes co-encapsulating either Asx-S or Asx-R and Cap showed that the activity of 
Asx-S/Cap-lipo was lower than the additive activity of liposomes encapsulating the individual agents 
at each ratio studied (Fig. 5A). However, Asx-R/Cap-lipo at a ratio of 1:2 exhibited remarkable 
synergistic activity (Figs. 5B and C), suggesting that the optimal ratio of Asx-R and Cap in liposomal 
membranes is likely 1:2, which is different from the optimal ratio found for synthetic Asx and Cap 
(i.e., 2:1). As the molar ratio of the stereoisomers in synthetic Asx is known to be 
Asx-S/Asx-R/Asx-meso=1:1:2 [21], the relative molar ratio of Asx-R in 1 mol of synthetic Asx is 
presumed to be 0.25. Based on this estimation, the relative amount of Asx-R in liposomes 
encapsulating synthetic Asx/Cap (2:1) would be 0.5, suggesting that the relative molar ratio of 
Asx-R/Cap in the Asx-R/Cap-lipo was 1:2. This estimation is thought to be consistent with the results 
shown in Fig. 5. 
14 
 
 To elucidate the mechanism of the synergistic activity of Asx-R/Cap-lipo, the BDEs at the 
active sites of Asx-R and Cap, namely H-C3 of Asx-R and H-C7 of Cap, under the complex 
conditions were individually compared with those of either Asx-R or Cap alone. Surprisingly, the 
BDEs of both Asx-R and Cap were mostly unchanged under both the simple and complex conditions, 
indicating that the reactivity of the active sites of both antioxidants was not affected by 
intermolecular interactions. On the other hand, results of a computational chemistry analysis found 
that the electronic state of the polyene moiety of Asx-R was markedly changed upon intermolecular 
interaction with Cap (Fig. 8), whereas the electronic state of Cap was largely unaffected. In particular, 
electronic charges on the C7, C8, C9, C12, and C14 atoms in Asx-R were markedly changed via 
intermolecular interaction with Cap (Fig. 8B). Additionally, visible absorption spectra also indicated 
that the electronic state of Asx-R was influenced by intermolecular interactions (Fig. 7), similar to 
the changes found for the electronic state of Asx-S upon co-encapsulation with α-T3 in our previous 
study [11]. Based on these results, changes in the electronic state of the Asx-R polyene moiety by 
intermolecular interaction with Cap may be responsible for the synergistic enhancement of the 
antioxidative activity of Asx. With regard to the formation of intermolecular interactions between 
Asx stereoisomers and other antioxidants, the ideal partner for Asx-R was Cap, whereas that for 
Asx-S was α-T3. As these differences are thought to result from structural properties of the paired 
compound for Asx, it is important to take into account the properties of the compounds to be 
combined with Asx as antioxidative activity enhancers.  
 As to the distribution of the antioxidant molecules in the liposomal membranes, since 
liposomes composed of EPC have high membrane fluidity, the antioxidant molecules should freely 
distribute in the membranes. In addition, our previous study reported that Asx encapsulated in the 
liposomal membranes can form both intermolecular and intramolecular hydrogen bonding in the 
membrane [6]. Regarding intermolecular interaction, we reported that the two terminal rings of Asx 
interact with the hydrophilic polar region of membrane phospholipids. In the case of intramolecular 
interaction, the hydroxyl and carbonyl groups of Asx form intramolecular hydrogen-bonded 
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five-membered ring, which increases the hydrophobicity of Asx advantageous for its location inside 
the membrane. Therefore, the terminal rings of Asx can be located either inside the membrane or 
at/near the membrane surface. Similarly to Asx, we previously reported that the phenolic hydrogen 
and acetylic oxygen of Cap possibly form hydrogen bonds with polar groups of membrane 
phospholipids, resulting in close location of the reaction site C7-benzyl carbon to the membrane 
surface [12]. Also, Cap forms an intramolecular hydrogen bond, and the hydrogen-bonded 
intramolecular five membered ring formation should increase the hydrophobicity of the ring moiety, 
which causes the vanillyl region of Cap to enter into the interior of the membrane. Hence, Cap can 
also be located either inside the membrane or at/near the surface of the membranes. Considering 
these findings, the antioxidant molecules can freely move in the liposomal membranes, such as from 
inner leaflets to outer ones. Consequently, it was suggested that both Asx, especially Asx-R, and Cap 
existing either inside the membrane or at/near the membrane surfaces could form intermolecular 
interactions in the each region, and exert synergistic antioxidative activity. 
 Based on the findings in the present study and our previous studies, it is suggested that 
antioxidants, such as Cap and α-T3, that can intermolecularly interact with Asx at the terminal ring 
and polyene moieties could act as enhancers of the antioxidative activity of Asx. Although we have 
shown the usefulness of liposomes co-encapsulating Asx and other antioxidants (Cap and α-T3) that 
can enhance the function of Asx in vitro, demonstration of the antioxidative capacity of those 
liposomes in vivo is needed for future therapeutic applications involving the treatment of various 
ROS-related diseases.  
 In conclusion, we found that the antioxidant Cap can enhance the antioxidative activity of 
Asx upon co-encapsulation into liposomal membranes. The stereochemistry of Asx was found to be 
an important factor for effective formation of intermolecular interactions to exert synergistic 
antioxidative activities of Asx-R/Cap-lipo. The optimal ratio of Asx-R/Cap in liposomes was 
determined to be 1:2. Moreover, changes in the electronic state of the polyene moiety of Asx-R via 
intermolecular interaction with Cap were suggested to be crucial for the synergistic enhancement of 
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the antioxidative activity. These results suggest that antioxidative compounds that can induce 
changes in the electronic state of Asx via intermolecular interaction should work as enhancers of Asx 
function and that liposomes co-encapsulating Asx and such antioxidants may offer a hopeful 
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Fig. 1. Chemical structures of astaxanthin (Asx); stereoisomers of Asx: 3R,3’R-form (Asx-R), 
3S,3’S-form (Asx-S), and 3R,3’S-meso form (Asx-meso); capsaicin (Cap); and resveratrol (Res).  
 
Fig. 2. Hydroxyl radical scavenging activity of liposomes encapsulating Cap (Cap-lipo) and Res 
(Res-lipo). 
 Relative antioxidative activities of Cap-lipo (A) and Res-lipo (B) were evaluated by the 
decrease in fluorescence intensity of APF which fluoresces via reaction with hydroxyl radicals. The 
decrease rate of the fluorescence intensity of APF in each liposomal group was calculated as the 
hydroxyl radical scavenging activity by setting the control group (plain EPC liposomes) as 100%. 
Data are the mean ± S.D. (n=3). 
 
Fig. 3. Effect of liposomes co-encapsulating Asx and Res (Asx/Res-lipo) or Asx and Cap 
(Asx/Cap-lipo) on hydroxyl radical scavenging. 
 Relative hydroxyl radical scavenging activities of Asx/Res-lipo (A) and Asx/Cap-lipo (B) 
were evaluated using APF. White, gray, and black columns indicate the groups of Res- or Cap-lipo, 
Asx-lipo, and liposomes co-encapsulating two antioxidants, respectively. Additive values of the 
activity of each liposomal sample are denoted by dotted lines. (C) Results of the additive activity of 
Asx-lipo (1.88 µM) plus Cap-lipo (0.94 µM), which were respectively mixed in a test tube, and the 
synergistic antioxidative activity of Asx/Cap-lipo (Asx 1.88 µM/Cap 0.94 µM) are shown. With the 
control group (plain EPC liposomes) as 100%, the decreased percentage of the fluorescence intensity 
of APF in each group was calculated as the hydroxyl radical scavenging activity. Data are mean ± 





Fig. 4. Intermolecular interaction energies of Asx stereoisomers with Cap. 
 Intermolecular interaction energies of Asx stereoisomers with Cap were estimated using the 
Gaussian 09 program. 
 
Fig. 5. Comparison of antioxidative activities of Asx-S and Asx-R co-encapsulated with Cap into 
liposomes. 
 Relative hydroxyl radical scavenging activities of Asx-S/Cap-lipo (A) and Asx-R/Cap-lipo 
(B) were evaluated using APF. White, gray, and black bars show Cap-lipo (0.94 µM), Asx-S- or 
Asx-R-lipo (0.47-7.5 µM), and Asx-S/Cap- or Asx-R/Cap-lipo, respectively. The combined values of 
the activity of each liposome sample are denoted by dotted lines. (C) The additive hydroxyl radical 
scavenging activity of Asx-R-lipo (0.47 µM) and Cap-lipo (0.94 µM), which were respectively 
mixed in a test tube, and the synergistic activity of Asx-R/Cap-lipo (Asx-R 0.47 µM/Cap 0.94 µM) 
are shown. The decrease rate of the APF fluorescence intensity in each liposome group was 
calculated as the hydroxyl radical scavenging activity by setting the control group (plain EPC 
liposomes) as 100%. Data are mean ± S.D. from the results of three independent experiments. 
Significant difference; * P<0.05. 
 
Fig. 6. Influence of intermolecular interactions on bond dissociation energy (BDE) of the active 
sites of Asx-R and Cap. 
 The active sites of Asx-R (C3) and Cap (C7) are shown by dotted circles. The BDE of the 
active sites of Asx-R and Cap were calculated using the Gaussian 09 program as described in 
Material and Methods. The BDE of Asx-R alone and upon interaction with Cap, and that of Cap 
alone and upon interaction with Asx-R are indicated. 
 
Fig. 7. Visible absorption spectra of liposomes co-encapsulating Asx-R and Cap. 
 The visible absorption spectra of Asx-R/Cap-lipo (black solid line) and that of a suspension 
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containing Asx-R-lipo and Cap-lipo (gray dotted line) were measured. The absorption spectrum of 
EPC liposomes without antioxidants was subtracted from the absorption spectrum of each 
antioxidant-encapsulated liposome to cancel liposomal turbidity. The peaks of the absorption spectra 
of Asx-R/Cap-lipo and a suspension containing Asx-R-lipo and Cap-lipo are indicated by black and 
white arrows, respectively. 
 
Fig. 8. Influence of intermolecular interactions between Asx-R and Cap on electronic structures. 
 (A) Schematic showing intermolecular interactions of Asx-R half fragment A with Cap. (B) 
The electronic structure of Asx-R half fragment A upon interaction with Cap was compared with free 
Asx-R half fragment B. Electronic changes Δqi(complex-free) of Asx-R half fragment A complexed 
with Cap (closed circle, solid line) and free Asx-R half fragment B (open circle, dotted line) are 









9 11 13 
~ ~ ~ 





3R,3 'R-form (.A.sx-R) 
~OH 
~------~ HOT 




3R,3'S mesa-form (.A.sx-meso) 
14 
15 14' 12' 10' 
~ ~ ~ ~ 
15' 13' 11' 9' 
20' 19' 
HOQ 































'-_./ 40 "°§,e 
:.a ·;;; 
~ . ..- 30 ;.... ...... 0 ........ al 
9bJ) 











~ 50 ........ '-_./ 
~o 
40 :.a ·;;; 
~ .,_. 
;.... ...... 
u ........ c,:i 30 9bJ) 
o C ;.... . ..-
20 "'O bJ) 
£~ 








~ 20 '-_./ 
"°§,e 
·1""""1 • f"""4 
"'O > 15 ~ . ..-;.... ...... 
u ........ c,:i 
;;.... 
X bJ) 







0.94 1.88 3.75 7.5 0.94 1.88 3.75 7.5 
1.88 1.88 
1.88 3.75 7.5 15 30 1.88 3.75 7.5 15 30 
0.94 
Asx-lipo 1.88 µM 
+ 






















20 0 C 
1-.. ·-"d bl) 





Asx-S (µM) 0.47 0.94 1.88 3.75 7.5 0.47 0.94 1.88 3.75 7.5 








30 crj ·-1-.. _...., 
(.) - crj ;>-. 







Asx-R (µM) 0.47 0.94 1.88 3.75 7.5 0.47 0.94 1.88 3.75 7.5 





'--" * ]c 15 
;.a "> 
crj ·-1-.. _...., 
(.) - crj 10 ;>-. 
>< bl) 
o C 
1-.. ·-"d bl) 
;>-. C 





Asx-R-lipo 0.47 µM Asx-R/Cap-lipo 
+ (Asx-R 0.47 µM/Cap 0.94 µM) 













Bond dissociation energy 
(BDE) of active sites 
68.82 kcal/mol 
Asx-R-Cap complex 68.56 kcal/mol 
Cap 78.36 kcal/mol 
Asx-R-Cap complex 78.33 kcal/mol 
----· Additive value -- Co-encapsulation 
0.25 
470 483 



















400 450 500 550 600 












































































































































































































































































































































































































































 § ..... 
~ 
J 
~ 
OJ
 
(
!)
-
-
-
<q
 
..., ~ ~
 
0 I 
0 
I 
